KA
CVS icon

KLCM Advisors’s CVS Health CVS Stock Holding History

KLCM Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,215
Closed -$218K – 178
2025
Q1 		$218K Buy
+3,215
New +$192K 0.03% 156
2024
Q4 		– Sell
-3,215
Closed -$202K – 174
2024
Q3 		$202K Sell
3,215
-400
-11% -$23.3K 0.02% 157
2024
Q2 		$213K Sell
3,615
-1,109
-23% -$69.4K 0.03% 144
2024
Q1 		$377K Buy
4,724
+1,652
+54% +$126K 0.05% 113
2023
Q4 		$243K Buy
3,072
+2
+0.1% +$142 0.04% 130
2023
Q3 		$214K Buy
3,070
+2
+0.1% +$142 0.04% 124
2023
Q2 		$212K Buy
+3,068
New +$218K 0.04% 125
2022
Q4 		– Sell
-3,223
Closed -$307K – 129
2022
Q3 		$307K Buy
3,223
+962
+43% +$95.2K 0.07% 97
2022
Q2 		$210K Buy
+2,261
New +$221K 0.05% 103
2019
Q4 		– Sell
-4,344
Closed -$274K – 109
2019
Q3 		$274K Buy
4,344
+116
+3% +$6.87K 0.07% 80
2019
Q2 		$230K Sell
4,228
-170
-4% -$9.15K 0.06% 87
2019
Q1 		$237K Buy
+4,398
New +$271K 0.06% 84
2015
Q3 		– Sell
-4,499
Closed -$472K – 87
2015
Q2 		$472K Buy
+4,499
New +$460K 0.12% 53

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KLCM Advisors's CVS Position: Q2 2025 in Review

KLCM Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,215 shares — an estimated $218K sold.

KLCM Advisors first reported a position in CVS in Q2 2015 and held it in 13 quarters. The position peaked at $472K in Q2 2015. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • KLCM Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • KLCM Advisors sold 3,215 CVS Health shares in Q2 2025, an estimated $218K.
  • KLCM Advisors first reported a position in CVS Health in Q2 2015 and held it in 13 quarters.
  • KLCM Advisors's CVS Health position peaked at $472K in Q2 2015.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on KLCM Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.